LOGC logo

ContextLogic (LOGC) Company Overview

Profile

Full Name:

ContextLogic Inc.

Country:

United States

IPO:

October 19, 2018

Indexes:

Not included

Description:

LogicBio Therapeutics (LOGC) is a biotechnology company focused on developing gene therapies for genetic disorders. They use innovative technologies to deliver genetic material to cells, aiming to treat conditions like methylmalonic acidemia and other rare diseases, improving patients' lives through advanced medical solutions.

Key Details

Price

$7.92

Annual Revenue

$287.00 M(-49.74% YoY)

Annual EPS

-$13.36(+22.01% YoY)

Annual ROE

-91.35%

Beta

0.56

Events Calendar

Earnings

Next earnings date:

Mar 4, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 12, 2023

Analyst ratings

Recent major analysts updates

Aug 22, 22 Chardan Capital
Buy
May 17, 22 Chardan Capital
Buy
May 10, 22 JMP Securities
Market Outperform
Feb 3, 22 William Blair
Market Perform
Feb 2, 22 Chardan Capital
Hold
Dec 23, 21 Chardan Capital
Buy
Nov 17, 21 Barclays
Overweight
Nov 16, 21 JMP Securities
Market Outperform
Jun 7, 21 HC Wainwright & Co.
Buy
Mar 4, 21 JMP Securities
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ContextLogic?
  • Does ContextLogic pay dividends?
  • What sector is ContextLogic in?
  • What industry is ContextLogic in?
  • What country is ContextLogic based in?
  • When did ContextLogic go public?
  • Is ContextLogic in the S&P 500?
  • Is ContextLogic in the NASDAQ 100?
  • Is ContextLogic in the Dow Jones?
  • When was ContextLogic's last earnings report?
  • When does ContextLogic report earnings?
  • Should I buy ContextLogic stock now?

What is the ticker symbol for ContextLogic?

The ticker symbol for ContextLogic is NASDAQ:LOGC

Does ContextLogic pay dividends?

No, ContextLogic does not pay dividends

What sector is ContextLogic in?

ContextLogic is in the Consumer Cyclical sector

What industry is ContextLogic in?

ContextLogic is in the Internet Retail industry

What country is ContextLogic based in?

ContextLogic is headquartered in United States

When did ContextLogic go public?

ContextLogic's initial public offering (IPO) was on October 19, 2018

Is ContextLogic in the S&P 500?

No, ContextLogic is not included in the S&P 500 index

Is ContextLogic in the NASDAQ 100?

No, ContextLogic is not included in the NASDAQ 100 index

Is ContextLogic in the Dow Jones?

No, ContextLogic is not included in the Dow Jones index

When was ContextLogic's last earnings report?

ContextLogic's most recent earnings report was on Nov 7, 2024

When does ContextLogic report earnings?

The next expected earnings date for ContextLogic is Mar 4, 2025

Should I buy ContextLogic stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions